Telix Pharmaceuticals Ltd Adr (TLX)

Jan 21, 2026

Telix Pharmaceuticals (NASDAQ:TLX) Strengthens Clinical Nuclear Medicine - Kalkine Media

Jan 21, 2026

Jan 21, 2026

Stock of the day: Telix Pharmaceuticals - IG Group

Jan 21, 2026

Jan 19, 2026

RBC Capital upgrades Telix Pharmaceuticals stock rating to Outperform - Investing.com

Jan 19, 2026

Jan 16, 2026

Prostate scan trial aims to reduce unnecessary biopsies for men - stocktitan.net

Jan 16, 2026

Jan 13, 2026

Telix Pharmaceuticals Within The Evolving Precision Oncology Space - Kalkine Media

Jan 13, 2026

Jan 09, 2026

Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 – TLX - GlobeNewswire Inc.

Jan 09, 2026

Jan 09, 2026

Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your RightsTLX - Sahm

Jan 09, 2026

Jan 09, 2026

Here's What Analysts Think About Telix Pharmaceuticals (TLX) - Finviz

Jan 09, 2026

Jan 09, 2026

Shareholders that lost money on Telix Pharmaceuticals Ltd.(TLX) should contact The Gross Law Firm about pending Class ActionTLX - Sahm

Jan 09, 2026

Jan 08, 2026

Telix Pharmaceuticals Ltd. Sued for Securities Law ViolationsContact Levi & Korsinsky Before January 9, 2026 to Discuss Your RightsTLX - Finviz

Jan 08, 2026

Jan 08, 2026

Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman - Barchart.com

Jan 08, 2026

Jan 08, 2026

Health conference talk to spotlight Telix therapeutic pipeline and products - Stock Titan

Jan 08, 2026

Jan 06, 2026

TLX Deadline: TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm - Barchart.com

Jan 06, 2026

Jan 03, 2026

TLX 6-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures - Sahm

Jan 03, 2026

Jan 02, 2026

FCX IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Freeport-McMoRan Inc. Investors to Secure Counsel Before Important January 12 Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.

Jan 02, 2026

Jan 02, 2026

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 9, 2026 in Telix Pharmaceuticals Ltd. LawsuitTLX - Sahm

Jan 02, 2026

Dec 31, 2025

TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - Barchart.com

Dec 31, 2025

Dec 30, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages F5, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Dec 30, 2025

Dec 30, 2025

Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX)January 9, 2026 Deadline to JoinContact Levi & Korsinsky - Sahm

Dec 30, 2025

Dec 23, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages F5, Inc. Stockholders to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Dec 23, 2025

Dec 21, 2025

Prostate scans reshaped treatment for 67% of men in China trial - Stock Titan

Dec 21, 2025

Dec 17, 2025

[6-K] Telix Pharmaceuticals Ltd Current Report (Foreign Issuer) | TLX SEC FilingForm 6-K - Stock Titan

Dec 17, 2025

Dec 16, 2025

Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately - Finviz

Dec 16, 2025

Dec 16, 2025

Telix Pharma (TLX) Makes Progress With New Study - Finviz

Dec 16, 2025

Dec 15, 2025

RBC Capital initiates Telix Pharmaceuticals stock with Sector Perform rating - Investing.com

Dec 15, 2025

Dec 10, 2025

Telix (ASX: TLX) teams with Varian to integrate PSMA-PET imaging into EBRT - Stock Titan

Dec 10, 2025

Dec 08, 2025

Telix Pharmaceuticals (TLX) files Form 6-K on first ProstACT Global patient - Stock Titan

Dec 08, 2025

Dec 02, 2025

ATTENTION NASDAQ: TLX INVESTORS: Contact Berger Montague About a Telix Pharmaceuticals Ltd. Class Action Lawsuit - Stock Titan

Dec 02, 2025

Nov 28, 2025

Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman - Finviz

Nov 28, 2025

Nov 26, 2025

Telix Pharmaceuticals (TLX) Hit with Investor Lawsuit Alleging Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman - Finviz

Nov 26, 2025

Nov 25, 2025

Investors in Telix Pharmaceuticals Ltd. Should Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your RightsTLX - Finviz

Nov 25, 2025

Nov 25, 2025

Berger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors After Class Action Filing - Stock Titan

Nov 25, 2025

Nov 24, 2025

TLXTelix Pharmaceuticals Ltd ADR Latest Stock News & Market Updates - Stock Titan

Nov 24, 2025